Solid Biosciences Ownership | Who Owns Solid Biosciences?
Solid Biosciences Ownership Summary
Solid Biosciences is owned by 193.17% institutional investors, 0.52% insiders. Algert global is the largest institutional shareholder, holding 0% of SLDB shares. Fidelity Select Biotechnology is the top mutual fund, with 4.53% of its assets in Solid Biosciences shares.
SLDB Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Solid Biosciences | 193.17% | 0.52% | -93.70% |
Sector | Healthcare Stocks | 279.18% | 10.62% | -189.80% |
Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Algert global | - | - | - |
Prudential financial | - | - | - |
Parallel advisors | 7.00 | - | $28.00 |
Sherbrooke park advisers | - | - | - |
Engineers gate manager lp | - | - | - |
Two sigma advisers, lp | - | - | - |
Belvedere trading | - | - | - |
Corton capital | - | - | - |
Laurion capital management lp | - | - | - |
Wellington management group llp | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Algert global | - | - | - |
Prudential financial | - | - | - |
Parallel advisors | 7.00 | - | $28.00 |
Sherbrooke park advisers | - | - | - |
Engineers gate manager lp | - | - | - |
Two sigma advisers, lp | - | - | - |
Belvedere trading | - | - | - |
Corton capital | - | - | - |
Laurion capital management lp | - | - | - |
Wellington management group llp | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Parallel advisors | 7.00 | - | - |
Belvedere trading | - | - | -901.00 |
Corton capital | - | - | -10.15K |
Sherbrooke park advisers | - | - | -15.77K |
Engineers gate manager lp | - | - | -21.62K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Laurion capital management lp | - | - | -255.08K |
Wellington management group llp | - | - | -124.55K |
Prudential financial | - | - | -109.11K |
Cubist systematic strategies | - | - | -65.61K |
Los angeles capital management | - | - | -42.99K |
Sold Out
Holder | Change |
---|---|
Belvedere trading | -901.00 |
Corton capital | -10.15K |
Sherbrooke park advisers | -15.77K |
Engineers gate manager lp | -21.62K |
Algert global | -22.09K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 127 | 33.68% | 78,847,007 | 117.02% | 193 | 2.44% | 91 | 78.43% | 17 | -5.56% |
Dec 31, 2024 | 1 | - | 7 | - | - | - | - | - | - | - |
Sep 30, 2024 | 1 | - | 7 | - | - | - | - | -100.00% | - | - |
Jun 30, 2024 | 1 | - | 7 | 16.67% | - | - | 1 | - | - | - |
Mar 31, 2024 | 1 | - | 6 | - | - | - | - | - | - | - |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Select Biotechnology | 3.51M | 4.53% | - |
Vanguard Total Stock Mkt Idx Inv | 1.91M | 2.46% | - |
Vanguard US Total Market Shares ETF | 854.68K | 1.12% | - |
Franklin Biotechnology Discv A(acc)USD | 791.40K | 1.02% | - |
iShares Russell 2000 ETF | 663.02K | 0.86% | 324.00 |
Franklin Biotechnology Discovery A | 449.30K | 0.58% | - |
iShares Biotechnology ETF | 407.23K | 0.53% | -5.32K |
International Biotechnology Ord | 355.70K | 0.46% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 342.97K | 0.44% | - |
Fidelity Small Cap Index | 239.09K | 0.31% | 7.22K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Mar 11, 2025 | Kahn Clare | - | Buy | $9.92K |
Feb 19, 2025 | Bain Capital Life Sciences Investors, LLC | - | Buy | $4.03M |
Feb 19, 2025 | Bain Capital Life Sciences Investors, LLC | - | Buy | $6.44K |
Feb 19, 2025 | PERCEPTIVE ADVISORS LLC | Buy | $20.15M | |
Feb 19, 2025 | RA CAPITAL MANAGEMENT, L.P. | - | Buy | $3.72K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | - |
2025 Q1 | 6 | 10 |
2024 Q4 | - | 5 |
2024 Q3 | - | - |
2024 Q2 | 1 | 1 |
SLDB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools